Saturday, 7 November 2026European Markets

FONCIERE INEA, SHURGARD, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Real Estate Services Industry.

Loading stream...

(vianews) - fonciere inea (inea.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate services industry.

financial asset price forward dividend yield return on equity
fonciere inea (inea.pa) €37.50 7.2% 7.46%
shurgard (shur.br) €42.99 2.86% 17.85%
galimmo (galim.pa) €15.10 2.35% 2.01%
fin.etang berre (berr.pa) €11.20 0.99% 7.08%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. fonciere inea (inea.pa)

7.2% forward dividend yield and 7.46% return on equity

fonciere inea s.a., a real estate investment company, engages in owning and managing business real estate properties in france. as of december 31, 2010, its property portfolio consisted of 111 buildings. the company was founded in 2005 and is based in paris, france.

earnings per share

as for profitability, fonciere inea has a trailing twelve months eps of €3.84.

pe ratio

fonciere inea has a trailing twelve months price to earnings ratio of 9.77. meaning, the purchaser of the share is investing €9.77 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.46%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, fonciere inea's stock is considered to be overbought (>=80).

volume

today's last reported volume for fonciere inea is 26 which is 95.6% below its average volume of 591.

more news about fonciere inea.

2. shurgard (shur.br)

2.86% forward dividend yield and 17.85% return on equity

shurgard self storage ltd, together with its subsidiaries, engages in the acquisition, development, and operation of self-storage facilities for business and personal use. the company also offers various ancillary services at its self-storage facilities consisting of sale of storage products and provision of protection through an independent insurance company for customers' stored goods. the company owns and/or operates 267 self-storage facilities and approximately 1.4 million net rentable square meters in france, the netherlands, the united kingdom, sweden, germany, belgium, and denmark. shurgard self storage ltd was founded in 1995 and is based in luxembourg, luxembourg.

earnings per share

as for profitability, shurgard has a trailing twelve months eps of €5.89.

pe ratio

shurgard has a trailing twelve months price to earnings ratio of 7.3. meaning, the purchaser of the share is investing €7.3 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.85%.

volume

today's last reported volume for shurgard is 13717 which is 71.23% below its average volume of 47679.

volatility

shurgard's last week, last month's, and last quarter's current intraday variation average was a positive 1.26%, a negative 0.16%, and a positive 1.60%.

shurgard's highest amplitude of average volatility was 1.31% (last week), 1.10% (last month), and 1.60% (last quarter).

revenue growth

year-on-year quarterly revenue growth grew by 7.5%, now sitting on 348.12m for the twelve trailing months.

more news about shurgard.

3. galimmo (galim.pa)

2.35% forward dividend yield and 2.01% return on equity

galimmo sca operates as a real estate company in europe. as of december 31, 2021, it owned and managed 52 shopping malls. galimmo sca was formerly known as c&co sca and changed its name to galimmo sca in september 2016. the company was incorporated in 1902 and is headquartered in paris, france. galimmo sca is a subsidiary of galimmo real estate.

earnings per share

as for profitability, galimmo has a trailing twelve months eps of €0.29.

pe ratio

galimmo has a trailing twelve months price to earnings ratio of 52.07. meaning, the purchaser of the share is investing €52.07 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.01%.

more news about galimmo.

4. fin.etang berre (berr.pa)

0.99% forward dividend yield and 7.08% return on equity

financiere et immobiliere de l'etang de berre et de la mediterranee société anonyme engages in the caravanning, parking and restaurant rental businesses. the company is headquartered in carry-le-rouet, france.

earnings per share

as for profitability, fin.etang berre has a trailing twelve months eps of €6.82.

pe ratio

fin.etang berre has a trailing twelve months price to earnings ratio of 1.64. meaning, the purchaser of the share is investing €1.64 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.08%.

moving average

fin.etang berre's worth is below its 50-day moving average of €11.27 and way above its 200-day moving average of €10.02.

yearly top and bottom value

fin.etang berre's stock is valued at €11.20 at 11:40 est, below its 52-week high of €11.50 and way higher than its 52-week low of €8.80.

more news about fin.etang berre.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com